Safety margins of hepatocellular carcinoma demonstrated by 3-dimensional fused images of computed tomographic hepatic arteriography/unenhanced computed tomography: Prognostic significance in patients who underwent transcatheter arterial chemoembolization

Journal of Computer Assisted Tomography

Volumn 34, Issue 5, 2010, Pages 712-719

  Tajima, Tsuyoshi ^a   Nishie, Akihiro ^a   Asayama, Yoshiki ^a   Ishigami, Kousei ^a   Ushijima, Yasuhiro ^a   Kakihara, Daisuke ^a   Honda, Hiroshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Chemoembolization; Computed tomography; CT angiography; Fusion technology; Liver; Safety margin

Indexed keywords

COMPUTERIZED TOMOGRAPHY; MULTIVARIANT ANALYSIS; PATIENT TREATMENT;

3-DIMENSIONAL; CHEMOEMBOLIZATION; COMPUTED TOMOGRAPHIC; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTED TOMOGRAPHY; FUSION TECHNOLOGY; HEPATOCELLULAR CARCINOMA; LIPIODOL; LOCAL RECURRENCE; SAFETY MARGIN;

IMAGE FUSION;

CHLOROTRIANISENE; EPIRUBICIN; IODINATED POPPYSEED OIL; CONTRAST MEDIUM;

ADULT; AGED; ARTICLE; CHEMOEMBOLIZATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; LIVER ARTERIOGRAPHY; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; THREE DIMENSIONAL IMAGING; TREATMENT OUTCOME; TUMOR RECURRENCE; ANGIOGRAPHY; CHI SQUARE DISTRIBUTION; COMPUTER ASSISTED DIAGNOSIS; LIVER TUMOR; METHODOLOGY; MIDDLE AGED; RADIOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGRAPHY; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; HUMANS; IMAGING, THREE-DIMENSIONAL; IODIZED OIL; LIVER NEOPLASMS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 77958143105     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/RCT.0b013e3181e1d241     Document Type: Article

References (35)

1. John AR, Khan S, Mirza DF, et al. Multivariate and univariate analysis of prognostic factors following resection in HCC: The Birmingham experience. Dig Surg. 2006;23:103-109.
2. Nakamura H, Tanaka T, Hori S, et al. Transcatheter embolization of hepatocellular carcinoma: Assessment of efficacy in cases of resection following embolization. Radiology. 1983;147:401-405.
3. Hsu HC, Wei TC, Tsang YM, et al. Histologic assessment of resected hepatocellular carcinoma after transcatheter hepatic arterial embolization. Cancer. 1986;57:1184-1191.
4. Tanaka K, Inoue S, Numata K, et al. Color Doppler sonography of hepatocellular carcinoma before and after treatment by transcatheter arterial embolization. AJR Am J Roentgenol. 1992;158:541-546.
5. Kanematsu T, Matsumata T, Shirabe K, et al. A comparative study of hepatic resection and transcatheter arterial embolization for the treatment of primary hepatocellular carcinoma. Cancer. 1993; 71:2181-2186.
6. Matsui O, Kadoya M, Yoshikawa J, et al. Small hepatocellular carcinoma: Treatment with subsegmental transcatheter arterial embolization. Radiology. 1993;188:79-83.
7. Hayashi K, Ina H, Tezuka M, et al. Local therapeutic results of computed tomographyYguided transcatheter arterial chemoembolization for hepatocellular carcinoma: Results of 265 tumors in 79 patients. Cardiovasc Intervent Radiol. 2007;30:1144-1155.
8. Miyayama S, Matsui O, Yamashiro M, et al. Ultraselective transcatheter arterial chemoembolization with a 2-F tip microcatheter for small hepatocellular carcinomas: Relationship between local tumor recurrence and visualization of the portal vein with iodized oil. J Vasc Interv Radiol. 2007;18:365-376.
9. Uchida H, Ohishi H, Matsuo N, et al. Transcatheter hepatic segmental arterial embolization using lipiodol mixed with an anticancer drug and gelfoam particles for hepatocellular carcinoma. Cardiovasc Intervent Radiol. 1990;13:140-145. (Pubitemid 20269112)
10. Imaeda T, Yamawaki Y, Seki M, et al. Lipiodol retention and massive necrosis after lipiodol-chemoembolization of hepatocellular carcinoma: Correlation between computed tomography and histopathology. Cardiovasc Intervent Radiol. 1993;16:209-213.
11. Nonami T, Harada A, Kurokawa T, et al. Hepatic resection for hepatocellular carcinoma. Am J Surg. 1997;173:288-291.
12. Nagasue N, Uchida M, Makino Y, et al. Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology. 1993;105:488-494.
13. Laurent C, Blanc JF, Nobili S, et al. Prognostic factors and longterm survival after hepatic resection for hepatocellular carcinoma originating from noncirrhotic liver. J Am Coll Surg. 2005;201:656-662.
14. Kosuge T, Makuuchi M, Takayama T, et al. Long-term results after resection of hepatocellular carcinoma: Experience of 480 cases. Hepatogastroenterology. 1993;40:328-332.
15. Hanazaki K, Kajikawa S, Shimozawa N, et al. Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma. J Am Coll Surg. 2000;191:381-388.
16. Nanashima A, Sumida Y, Abo T, et al. Comparison of survival between anatomic and non-anatomic liver resection in patients with hepatocellular carcinoma: Significance of surgical margin in non-anatomic resection. Acta Chir Belg. 2008;108:532-537.
17. Lai EC, Ng IO, You KT, et al. Hepatectomy for large hepatocellular carcinoma: The optimal resection margin. World J Surg. 1991;15: 141-145.
18. Chau GY, Lui WY, Tsay SH, et al. Prognostic significance of surgical margin in hepatocellular carcinoma resection: An analysis of 165 childs' a patients. J Surg Oncol. 1997;66:122-126.
19. Poon RT, Fan ST, Ng IO, et al. Significance of resection margin in hepatectomy for hepatocellular carcinoma: A critical reappraisal. Ann Surg. 2000;231:544-551.
20. Ochiai T, Takayama T, Inoue K, et al. Hepatic resection with and without surgical margins for hepatocellular carcinoma in patients with impaired liver function. Hepatogastroenterology. 1999;46:1885-1889.
21. Sasaki Y, Yamada T, Tanaka H, et al. Risk of recurrence in a long-term follow-up after surgery in 417 patients with hepatitis BY or hepatitis CYrelated hepatocellular carcinoma. Ann Surg. 2006;244:771-780.
22. Shi M, Guo RP, Lin XJ, et al. Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: A prospective randomized trial. Ann Surg. 2007;245:36-43.
23. Zytoon AA, Ishii H, Murakami K, et al. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. a registry report of the impact of risk factors on outcome. Jpn J Clin Oncol. 2007; 37:658-672.
24. Berber E, Siperstein A. Local recurrence after laparoscopic radiofrequency ablation of liver tumors: An analysis of 1032 tumors. Ann Surg Oncol. 2008;15:2757-2764.
25. Fujioka C, Horiguchi J, Ishifuro M, et al. A feasibility study: Evaluation of radiofrequency ablation therapy to hepatocellular carcinoma using image registration of preoperative and postoperative CT. Acad Radiol. 2006;13:986-994.
26. Nakazawa T, Kokubu S, Shibuya A, et al. Radiofrequency ablation of hepatocellular carcinoma: Correlation between local tumor progression after ablation and ablative margin. AJR Am J Roentgenol. 2007; 188:480-488.
27. Nishimine K, Uchida H, Matsuo N, et al. Segmental transarterial chemoembolization with lipiodol mixed with anticancer drugs for nonresectable hepatocellular carcinoma: Follow-up CT and therapeutic results. Cancer Chemother Pharmacol. 1994;33(suppl):S60-S68.
28. Tajima T, Honda H, Taguchi K, et al. Sequential hemodynamic change in hepatocellular carcinoma and dysplastic nodules: CT angiography and pathologic correlation. AJR Am J Roentgenol. 2002;178: 885-897.
29. Nakashima Y, Nakashima O, Tanaka M, et al. Portal vein invasion and intrahepatic micrometastasis in small hepatocellular carcinoma by gross type. Hepatol Res. 2003;26:142-147.
30. Lee JH, Won JH, Park SI, et al. Transcatheter arterial chemoembolization of hepatocellular carcinoma with hepatic arteriovenous shunt after temporary balloon occlusion of hepatic vein. J Vasc Interv Radiol. 2007;18:377-382.
31. Herber S, Biesterfeld S, Franz U, et al. Correlation of multislice ct and histomorphology in HCC following TACE: Predictors of outcome. Cardiovasc Intervent Radiol. 2008;31:768-777.
32. Chung YH. A strategy for early detection of recurrent hepatocellular carcinoma following initial remission by transcatheter arterial chemoembolization. Intervirology. 2005;48:46-51.
33. Lee JK, Chung YH, Song BC, et al. Recurrences of hepatocellular carcinoma following initial remission by transcatheter arterial chemoembolization. J Gastroenterol Hepatol. 2002;17:52-58.
34. Nishie A, Yoshimitsu K, Asayama Y, et al. Radiologic detectability of minute portal venous invasion in hepatocellular carcinoma. AJR Am J Roentgenol. 2008;190:81-87.
35. Higashihara H, Okazaki M. Transcatheter arterial chemoembolization of hepatocellular carcinoma: A Japanese experience. Hepatogastroenterology. 2002;49:72-78.